Literature DB >> 7564809

Contents of "ecstasy".

K Wolff, A W Hay, K Sherlock, M Conner.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7564809     DOI: 10.1016/s0140-6736(95)91774-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Chronic cognitive impairment in users of 'ecstasy' and cannabis.

Authors:  Anthony Klugman; John Gruzelier
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

2.  Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents.

Authors:  Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

3.  Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.

Authors:  H Valerie Curran; Suzanne L Verheyden
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

Review 4.  Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?

Authors:  William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

Review 5.  Ketamine : from medicine to misuse.

Authors:  Kim Wolff; Adam R Winstock
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.

Authors:  John Martin Corkery; Wan-Chu Hung; Hugh Claridge; Christine Goodair; Caroline S Copeland; Fabrizio Schifano
Journal:  J Psychopharmacol       Date:  2021-06-05       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.